ARCHIVES

Funding Opportunities: RFA Available: Teams For Molecular Target Assessment

This article is from The Cancer Letter archive.

Vol. 25 No. 45 | November 26, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Approves New Indication For Anticoagulant Frangmin

May 25, 2007

New Group Review First NTP Reports, Gets Job On Permanent Basis, Wrangles Over Extrapolation

July 11, 1980

In Brief: fraud By Trainee Leads Collins To Retract Five Paper; Weinstein Retires At Columbia

November 1, 1996

Hawaii Epidemiology Studies Offer Opportunities For Major Impact On Cancer Incidence, Survival

January 4, 1985

FDA Approves Arranon For Leukemia And Lymphoma

December 30, 2005

In Brief: Cancer Program “Greatest Experiment And it Works,” ACS President tells Congress

June 25, 1976